Authors:
BOLD G
FASSLER A
CAPRARO HG
COZENS R
KLIMKAIT T
LAZDINS J
MESTAN J
PONCIONI B
ROSEL J
STOVER D
TINTELNOTBLOMLEY M
ACEMOGLU F
BECK W
BOSS E
ESCHBACH M
HURLIMANN T
MASSO E
ROUSSEL S
UCCISTOLL K
WYSS D
LANG R
Citation: G. Bold et al., NEW AZA-DIPEPTIDE ANALOGS AS POTENT AND ORALLY ABSORBED HIV-1 PROTEASE INHIBITORS - CANDIDATES FOR CLINICAL DEVELOPMENT, Journal of medicinal chemistry, 41(18), 1998, pp. 3387-3401
Authors:
LAZDINS JK
BOLD G
CAPRARO HG
COZENS R
FASSLER A
FLESCH G
KLIMKAIT T
LANG M
MESTAN J
PONCIONI B
ROSEL J
STOVER D
TINTELNOTBLOMLEY M
WALKER MR
WOODSCOOK K
Citation: Jk. Lazdins et al., PROFILE OF CGP-61755 - A NOVEL AND POTENT HIV-1 PROTEASE INHIBITOR THAT SHOWS ENHANCED ANTI-HIV ACTIVITY WHEN COMBINED WITH OTHER ANTIRETROVIRAL AGENTS IN-VITRO, Schweizerische medizinische Wochenschrift, 126(43), 1996, pp. 1849-1851
Authors:
FASSLER A
BOLD G
CAPRARO HG
COZENS R
MESTAN J
PONCIONI B
ROSEL J
TINTELNOTBLOMLEY M
LANG M
Citation: A. Fassler et al., AZA-PEPTIDE ANALOGS AS POTENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS WITH ORAL BIOAVAILABILITY, Journal of medicinal chemistry, 39(16), 1996, pp. 3203-3216
Authors:
LEROUX JC
COZENS R
ROESEL JL
GALLI B
KUBEL F
DOELKER E
GURNY R
Citation: Jc. Leroux et al., PHARMACOKINETICS OF A NOVEL HIV-1 PROTEASE INHIBITOR INCORPORATED INTO BIODEGRADABLE OR ENTERIC NANOPARTICLES FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION TO MICE, Journal of pharmaceutical sciences, 84(12), 1995, pp. 1387-1391
Authors:
ALTERI E
BOLD G
COZENS R
FAESSLER A
KLIMKAIT T
LANG M
LAZDINS J
PONCIONI B
ROESEL JL
SCHNEIDER P
WALKER M
WOODSCOOK K
Citation: E. Alteri et al., CGP-53437, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH POTENT ANTIVIRAL ACTIVITY, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2087-2092